Michael S Schechter - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael S Schechter

Showing results (71-80 of 130) with videos related to

Pageof 13

Sort By:

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 16, 2014

Pulmonary function outcomes for assessing cystic fibrosis careJeffrey S Wagener, Eric P Elkin, David J Pasta, et al.

Annals of the American Thoracic Society|August 20, 2015

Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic FibrosisDon B Sanders, Julia Emerson, Clement L Ren, et al.

Pediatric Pulmonology|February 24, 2012

Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosisSusanna A McColley, Clement L Ren, Michael S Schechter, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2025

Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosisWilliam T Harris, Elizabeth H Baker, Jennifer S Guimbellot, et al.

Pediatric Pulmonology|April 25, 2017

Risk factors for mortality before age 18 years in cystic fibrosisSusanna A McColley, Michael S Schechter, Wayne J Morgan, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 20, 2026

Obesity in adults with cystic fibrosis following prescription of elexacaftor/tezacaftor/ivacaftorJoshua S Ostrenga, Christina M Mingora, Sylvia Szentpetery, et al.

Pediatric Pulmonology|June 11, 2015

Risk factors for lung function decline in a large cohort of young cystic fibrosis patientsJonathan Cogen, Julia Emerson, Don B Sanders, et al.

Annals of the American Thoracic Society|December 9, 2017

Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United StatesGregory S Sawicki, Joshua Ostrenga, Kristofer Petren, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2020

Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosisGabriela R Oates, Elizabeth Baker, Steven M Rowe, et al.

American Journal of Clinical Pathology|June 14, 2014

Risk factors for quantity not sufficient sweat collection in infants 3 months or youngerMatthew N Collins, Cindy B Brawley, Courtney E McCracken, et al.

Pageof 13

Search research articles

Showing results (71-80 of 130) with videos related to

Sort By:

Pageof 13

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 16, 2014

Pulmonary function outcomes for assessing cystic fibrosis careJeffrey S Wagener, Eric P Elkin, David J Pasta, et al.

Annals of the American Thoracic Society|August 20, 2015

Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic FibrosisDon B Sanders, Julia Emerson, Clement L Ren, et al.

Pediatric Pulmonology|February 24, 2012

Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosisSusanna A McColley, Clement L Ren, Michael S Schechter, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2025

Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosisWilliam T Harris, Elizabeth H Baker, Jennifer S Guimbellot, et al.

Pediatric Pulmonology|April 25, 2017

Risk factors for mortality before age 18 years in cystic fibrosisSusanna A McColley, Michael S Schechter, Wayne J Morgan, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 20, 2026

Obesity in adults with cystic fibrosis following prescription of elexacaftor/tezacaftor/ivacaftorJoshua S Ostrenga, Christina M Mingora, Sylvia Szentpetery, et al.

Pediatric Pulmonology|June 11, 2015

Risk factors for lung function decline in a large cohort of young cystic fibrosis patientsJonathan Cogen, Julia Emerson, Don B Sanders, et al.

Annals of the American Thoracic Society|December 9, 2017

Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United StatesGregory S Sawicki, Joshua Ostrenga, Kristofer Petren, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2020

Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosisGabriela R Oates, Elizabeth Baker, Steven M Rowe, et al.

American Journal of Clinical Pathology|June 14, 2014

Risk factors for quantity not sufficient sweat collection in infants 3 months or youngerMatthew N Collins, Cindy B Brawley, Courtney E McCracken, et al.

Pageof 13